KLSE (MYR): TITIJYA (5239)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
0.255
Today's Change
0.00 (0.00%)
Day's Change
0.25 - 0.255
Trading Volume
17,400
Market Cap
345 Million
NOSH
1,352 Million
Latest Quarter
30-Sep-2024 [#1]
Announcement Date
29-Nov-2024
Next Quarter
31-Dec-2024
Est. Ann. Date
23-Feb-2025
Est. Ann. Due Date
01-Mar-2025
QoQ | YoY
-55.94% | 32.20%
Revenue | NP to SH
209,106.000 | 26,261.000
RPS | P/RPS
15.47 Cent | 1.65
EPS | P/E | EY
1.94 Cent | 13.13 | 7.62%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.92 | 0.28
QoQ | YoY
1.92% | 508.74%
NP Margin | ROE
12.56% | 2.11%
F.Y. | Ann. Date
30-Sep-2024 | 29-Nov-2024
Latest Audited Result
30-Jun-2024
Announcement Date
30-Oct-2024
Next Audited Result
30-Jun-2025
Est. Ann. Date
30-Oct-2025
Est. Ann. Due Date
27-Dec-2025
Revenue | NP to SH
254,857.000 | 25,767.000
RPS | P/RPS
18.85 Cent | 1.35
EPS | P/E | EY
1.91 Cent | 13.38 | 7.47%
DPS | DY | Payout %
0.00 Cent | 0.00% | 0.00%
NAPS | P/NAPS
0.91 | 0.28
YoY
483.62%
NP Margin | ROE
11.35% | 2.10%
F.Y. | Ann. Date
30-Jun-2024 | 30-Aug-2024
Revenue | NP to SH
160,160.000 | 8,112.000
RPS | P/RPS
11.85 Cent | 2.15
EPS | P/E | EY
0.60 Cent | 42.50 | 2.35%
DPS | DY | Payout %
-
NAPS | P/NAPS
-
QoQ | YoY
-68.52% | 32.2%
NP Margin | ROE
5.80% | 0.65%
F.Y. | Ann. Date
30-Sep-2024 | 29-Nov-2024
Last 10 FY Result | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 160,160 | 209,106 | 254,857 | 362,870 | 274,966 | 253,425 | 165,311 | 311,803 | 399,030 | 380,752 | 400,079 | 340,650 | -3.16% | |
PBT | 14,632 | 35,938 | 41,396 | 16,919 | 11,029 | 12,745 | 16,212 | 52,525 | 107,027 | 110,600 | 91,591 | 111,083 | -10.37% | |
Tax | -5,336 | -9,671 | -12,477 | -11,009 | -7,486 | -20,291 | -14,039 | -15,266 | -35,535 | -34,217 | -23,306 | -30,332 | -9.39% | |
NP | 9,296 | 26,267 | 28,919 | 5,910 | 3,543 | -7,546 | 2,173 | 37,259 | 71,492 | 76,383 | 68,285 | 80,751 | -10.77% | |
- | ||||||||||||||
NP to SH | 8,112 | 26,261 | 25,767 | 4,415 | 485 | -13,866 | -2,132 | 34,924 | 72,900 | 76,735 | 68,340 | 80,936 | -11.93% | |
- | ||||||||||||||
Tax Rate | 36.47% | 26.91% | 30.14% | 65.07% | 67.88% | 159.21% | 86.60% | 29.06% | 33.20% | 30.94% | 25.45% | 27.31% | - | |
Total Cost | 150,864 | 182,839 | 225,938 | 356,960 | 271,423 | 260,971 | 163,138 | 274,544 | 327,538 | 304,369 | 331,794 | 259,899 | -1.54% | |
- | ||||||||||||||
Net Worth | 1,243,839 | 1,243,839 | 1,227,556 | 1,178,335 | 1,044,737 | 1,072,050 | 1,102,217 | 1,315,603 | 1,236,652 | 650,630 | 532,287 | 472,823 | 11.17% |
Equity | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Worth | 1,243,839 | 1,243,839 | 1,227,556 | 1,178,335 | 1,044,737 | 1,072,050 | 1,102,217 | 1,315,603 | 1,236,652 | 650,630 | 532,287 | 472,823 | 11.17% | |
NOSH | 1,351,999 | 1,351,999 | 1,430,927 | 1,430,927 | 1,360,229 | 1,359,034 | 1,357,927 | 1,344,424 | 1,344,424 | 394,321 | 357,239 | 352,853 | 16.81% |
Ratio Analysis | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NP Margin | 5.80% | 12.56% | 11.35% | 1.63% | 1.29% | -2.98% | 1.31% | 11.95% | 17.92% | 20.06% | 17.07% | 23.70% | - | |
ROE | 0.65% | 2.11% | 2.10% | 0.37% | 0.05% | -1.29% | -0.19% | 2.65% | 5.89% | 11.79% | 12.84% | 17.12% | - |
Per Share | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 11.85 | 15.47 | 19.10 | 27.72 | 21.58 | 19.86 | 13.05 | 23.23 | 29.69 | 96.56 | 111.99 | 96.54 | -16.46% | |
EPS | 0.60 | 1.94 | 1.93 | 0.33 | 0.04 | -1.09 | -0.17 | 2.66 | 4.84 | 19.46 | 19.13 | 22.94 | -24.02% | |
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.25 | 0.00 | 0.00 | 4.50 | - | |
NAPS | 0.92 | 0.92 | 0.92 | 0.90 | 0.82 | 0.84 | 0.87 | 0.98 | 0.92 | 1.65 | 1.49 | 1.34 | -4.08% |
Adjusted Per Share Value based on latest NOSH - 1,351,999 | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RPS | 11.85 | 15.47 | 18.85 | 26.84 | 20.34 | 18.74 | 12.23 | 23.06 | 29.51 | 28.16 | 29.59 | 25.20 | -3.17% | |
EPS | 0.60 | 1.94 | 1.91 | 0.33 | 0.04 | -1.03 | -0.16 | 2.58 | 5.39 | 5.68 | 5.05 | 5.99 | -11.91% | |
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.15 | 0.25 | 0.00 | 0.00 | 1.17 | - | |
NAPS | 0.92 | 0.92 | 0.908 | 0.8716 | 0.7727 | 0.7929 | 0.8152 | 0.9731 | 0.9147 | 0.4812 | 0.3937 | 0.3497 | 11.17% |
Price Multiplier on Financial Quarter End Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 30/09/24 | 30/09/24 | 28/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 28/06/19 | 29/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | - | |
Price | 0.275 | 0.275 | 0.285 | 0.255 | 0.245 | 0.35 | 0.265 | 0.30 | 0.385 | 1.63 | 1.44 | 1.99 | - | |
P/RPS | 2.32 | 1.78 | 1.49 | 0.92 | 1.14 | 1.76 | 2.03 | 1.29 | 1.30 | 1.69 | 1.29 | 2.06 | -3.53% | |
P/EPS | 45.83 | 14.16 | 14.76 | 75.62 | 643.60 | -32.21 | -157.47 | 11.53 | 7.10 | 8.38 | 7.53 | 8.68 | 6.07% | |
EY | 2.18 | 7.06 | 6.78 | 1.32 | 0.16 | -3.10 | -0.64 | 8.67 | 14.09 | 11.94 | 13.28 | 11.53 | -5.72% | |
DY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.50 | 0.65 | 0.00 | 0.00 | 2.26 | - | |
P/NAPS | 0.30 | 0.30 | 0.31 | 0.28 | 0.30 | 0.42 | 0.30 | 0.31 | 0.42 | 0.99 | 0.97 | 1.49 | -15.99% |
Price Multiplier on Announcement Date | ||||||||||||||
AQR | T4Q | 30/06/24 | 30/06/23 | 30/06/22 | 30/06/21 | 30/06/20 | 30/06/19 | 30/06/18 | 30/06/17 | 30/06/16 | 30/06/15 | CAGR | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Date | 29/11/24 | 29/11/24 | 30/08/24 | 30/08/23 | 30/08/22 | 23/09/21 | 28/08/20 | 30/08/19 | 30/08/18 | 30/08/17 | 25/08/16 | 27/08/15 | - | |
Price | 0.255 | 0.255 | 0.27 | 0.29 | 0.245 | 0.34 | 0.52 | 0.295 | 0.345 | 1.50 | 1.60 | 1.81 | - | |
P/RPS | 2.15 | 1.65 | 1.41 | 1.05 | 1.14 | 1.71 | 3.99 | 1.27 | 1.16 | 1.55 | 1.43 | 1.87 | -3.08% | |
P/EPS | 42.50 | 13.13 | 13.98 | 86.00 | 643.60 | -31.29 | -309.00 | 11.34 | 6.36 | 7.71 | 8.36 | 7.89 | 6.55% | |
EY | 2.35 | 7.62 | 7.15 | 1.16 | 0.16 | -3.20 | -0.32 | 8.82 | 15.72 | 12.97 | 11.96 | 12.67 | -6.15% | |
DY | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.51 | 0.72 | 0.00 | 0.00 | 2.49 | - | |
P/NAPS | 0.28 | 0.28 | 0.29 | 0.32 | 0.30 | 0.40 | 0.60 | 0.30 | 0.38 | 0.91 | 1.07 | 1.35 | -15.69% |
PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.
NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.
Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.
All figures in '000 unless specified.
You means no more FREE vaccine from government soon. Vaccines are here to stay. Flu shot vaccine are here all this years.. Taken once a year.. and now after covid19.. more will be be taking it .
2021-10-31 16:20
Just average 1 more round at... 335.. now cost at 420...
keep another 6 months to see
2021-11-05 12:22
Buy more for what ? Get back to work la.
Titijaya Medical .. what have been achieved ? Medical industrial related- real estate ? Any progress from Sinopharm medical related biz ? And how is SINOMACH as collaborative partners regarding equipment for medical producing line and the construction and technology support do ?
Construction sudah resume ? Japan’s Tokyu Land Corp (TLC) RM1.5 billion Riveria City project in Brickfields, Kuala Lumpur apa progress ?
2021-11-24 10:11
I believe many weak holders have been squeezed out and probably it’s time to buy back Titijaya around 0.25 before operator push up to 0.45 again
2021-12-13 22:46
Deyyy, last time you called other weak holder when it's 0.4 and say operator will bring up to 0.7. what's make your expectation getting lower and lower? what's next? squeeze out weak holder and wait operator to bring up to 0.2?
2021-12-20 16:46
Penang will see the establishment of its first-ever ultra-modern logistics commercial complex in Bayan Lepas next year.
Titijaya Land Berhad and DHL Supply Chain (M) Sdn yesterday signed a Memorandum of Agreement (MoA) to develop the complex at a 20-acre mixed development site in Bayan Lepas
2022-03-28 10:19
BigZakar
second limit up is near!!!!!!!!!
2021-10-14 16:51